Location: Boston, MA
CIK: 0001346824 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value: $5.467B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A S | 5,909,742 | $912M | 16.7% | $154.32 | $53.69 | — | SPONSORED ADR | 04351P101 |
| — | FORMA THERAPEUTICS HLDGS INC | 9,011,651 | $449M | 8.2% | $49.84 | $46.49 | — | SHS | 34633R104 |
| — | CHEMOCENTRYX INC | 4,826,910 | $265M | 4.8% | $54.80 | $42.10 | — | COM | 16383L106 |
| PCVX | VAXCYTE INC | 5,283,818 | $261M | 4.8% | $49.38 * | $32.16 | +23.8% | COM | 92243G108 |
| TGTX | TG THERAPEUTICS INC | 8,825,849 | $236M | 4.3% | $26.76 * | $11.95 | +92.6% | COM | 88322Q108 |
| NKTX | NKARTA INC | 5,605,129 | $168M | 3.1% | $30.06 | $29.47 | 0.0% | COM | 65487U108 |
| AXSM | AXSOME THERAPEUTICS INC | 2,035,132 | $145M | 2.7% | $71.25 * | $68.14 | +14.4% | COM | 05464T104 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 3,825,008 | $140M | 2.6% | $36.67 * | $25.67 | +34.9% | COM | 71722W107 |
| — | SERES THERAPEUTICS INC | 4,750,000 | $134M | 2.5% | $28.31 | $28.31 | — | COM | 81750R102 |
| NVAX | NOVAVAX INC | 1,198,602 | $130M | 2.4% | $108.35 * | $38.25 | +218.5% | COM NEW | 670002401 |
| — | 89BIO INC | 4,736,214 | $122M | 2.2% | $25.66 | $26.08 | — | COM | 282559103 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 5,140,408 | $111M | 2.0% | $21.67 * | $24.09 | -4.8% | COM | 76243J105 |
| MGNX | MACROGENICS INC | 4,375,217 | $110M | 2.0% | $25.19 * | $17.37 | +57.2% | COM | 556099109 |
| — | EIDOS THERAPEUTICS INC | 2,163,271 | $109M | 2.0% | $50.53 | $20.34 | — | COM | 28249H104 |
| — | ITEOS THERAPEUTICS INC | 4,417,258 | $109M | 2.0% | $24.67 | $24.67 | — | COM | 46565G104 |
| — | ZOGENIX INC | 5,488,424 | $98.41M | 1.8% | $17.93 | $26.04 | — | COM NEW | 98978L204 |
| — | ADVERUM BIOTECHNOLOGIES INC | 9,410,860 | $96.93M | 1.8% | $10.30 | $10.49 | — | COM | 00773U108 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 11,329,581 | $90.41M | 1.7% | $7.98 | $3.01 | — | SPONDS ADR | 00653A107 |
| — | TRILLIUM THERAPEUTICS INC | 6,162,694 | $87.57M | 1.6% | $14.21 | $4.04 | — | COM NEW | 89620X506 |
| ARVN | ARVINAS INC | 3,672,872 | $86.72M | 1.6% | $23.61 * | $23.47 | +23.5% | COM | 04335A105 |
| — | RETROPHIN INC | 4,635,687 | $85.58M | 1.6% | $18.46 | $12.63 | — | COM | 761299106 |
| — | KALA PHARMACEUTICALS INC | 10,874,613 | $81.56M | 1.5% | $7.50 | $10.65 | — | COM | 483119103 |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | 2,589,904 | $78.29M | 1.4% | $30.23 | $30.22 | +0.7% | COM | 09203E105 |
| LEGN | LEGEND BIOTECH CORP | 2,408,292 | $74.34M | 1.4% | $30.87 | $42.56 | — | SPONSORED ADS | 52490G102 |
| — | IGM BIOSCIENCES INC | 982,723 | $72.53M | 1.3% | $73.81 | $28.47 | — | COM | 449585108 |
| KROS | KEROS THERAPEUTICS INC | 1,875,000 | $72.32M | 1.3% | $38.57 * | $30.81 | +28.7% | COM | 492327101 |
| VXRT | VAXART INC | 10,810,937 | $71.89M | 1.3% | $6.65 * | $8.91 | 0.0% | COM NEW | 92243A200 |
| WVE | WAVE LIFE SCIENCES LTD | 7,775,207 | $66.01M | 1.2% | $8.49 * | $17.26 | -36.5% | SHS | Y95308105 |
| PMVP | PMV PHARMACEUTICALS INC | 1,710,265 | $60.71M | 1.1% | $35.50 * | $36.80 | 0.0% | COM | 69353Y103 |
| DYN | DYNE THERAPEUTICS INC | 2,805,045 | $56.63M | 1.0% | $20.19 * | $21.96 | 0.0% | COM | 26818M108 |
| — | INOZYME PHARMA INC | 2,003,653 | $52.68M | 1.0% | $26.29 | $26.29 | — | COM | 45790W108 |
| GERN | GERON CORP | 30,126,299 | $52.42M | 1.0% | $1.74 * | $1.49 | +23.7% | COM | 374163103 |
| — | AKOUOS INC | 2,281,249 | $52.17M | 1.0% | $22.87 | $22.50 | — | COM | 00973J101 |
| — | ORCHARD THERAPEUTICS PLC | 12,315,213 | $50.62M | 0.9% | $4.11 | $10.43 | — | ADS | 68570P101 |
| CRDF | CARDIFF ONCOLOGY INC | 3,290,000 | $46.69M | 0.9% | $14.19 * | $6.60 | 0.0% | COM | 14147L108 |
| RLAY | RELAY THERAPEUTICS INC | 1,000,000 | $42.59M | 0.8% | $42.59 * | $38.13 | 0.0% | COM | 75943R102 |
| — | INHIBRX INC | 2,129,003 | $38.32M | 0.7% | $18.00 | $18.00 | — | COM | 45720L107 |
| ALEC | ALECTOR INC | 3,618,748 | $38.12M | 0.7% | $10.54 * | $23.90 | -32.3% | COM | 014442107 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 2,328,698 | $36.49M | 0.7% | $15.67 * | $27.24 | -43.9% | COM | 22663K107 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,165,184 | $34.14M | 0.6% | $29.30 * | $26.87 | -0.6% | COM | 03969K108 |
| ARDX | ARDELYX INC | 6,260,904 | $32.87M | 0.6% | $5.25 * | $6.19 | -3.0% | COM | 039697107 |
| — | VERONA PHARMA PLC | 5,100,000 | $31.82M | 0.6% | $6.24 | $6.24 | — | SPONSORED ADS | 925050106 |
| RLMD | RELMADA THERAPEUTICS INC | 781,290 | $29.39M | 0.5% | $37.62 * | $33.64 | +14.9% | COM | 75955J402 |
| — | SCPHARMACEUTICALS INC | 3,518,998 | $26.22M | 0.5% | $7.45 | $10.74 | — | COM | 810648105 |
| — | IMMUNOGEN INC | 7,040,485 | $25.35M | 0.5% | $3.60 | $3.60 | — | COM | 45253H101 |
| LRMR | LARIMAR THERAPEUTICS INC | 1,515,151 | $22.98M | 0.4% | $15.17 * | $11.65 | +8.7% | COM | 517125100 |
| — | SUTRO BIOPHARMA INC | 2,118,212 | $21.29M | 0.4% | $10.05 | $7.97 | — | COM | 869367102 |
| OCUL | OCULAR THERAPEUTIX INC | 2,727,272 | $20.75M | 0.4% | $7.61 * | $6.63 | +25.2% | COM | 67576A100 |
| — | PANDION THERAPEUTICS INC | 1,770,023 | $20.28M | 0.4% | $11.46 | $11.46 | — | COM | 698340106 |
| — | PREVAIL THERAPEUTICS INC | 1,915,568 | $19.5M | 0.4% | $10.18 | $13.03 | — | COM | 74140Y101 |
| — | CONCERT PHARMACEUTICALS INC | 1,858,474 | $18.25M | 0.3% | $9.82 | $8.84 | — | COM | 206022105 |
| — | SATSUMA PHARMACEUTICALS INC | 4,681,858 | $18.21M | 0.3% | $3.89 | $15.01 | — | COM | 80405P107 |
| MIST | MILESTONE PHARMACEUTICALS INC | 2,418,798 | $17.71M | 0.3% | $7.32 * | $7.17 | 0.0% | COM | 59935V107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,023,067 | $15.1M | 0.3% | $14.76 * | $15.23 | +0.1% | COM | 87164F105 |
| — | BCTG ACQUISITION CORP | 1,250,000 | $12.95M | 0.2% | $10.36 | $10.36 | — | COM | 05492W103 |
| — | REPARE THERAPEUTICS INC | 409,000 | $12.59M | 0.2% | $30.77 | $31.02 | — | COM | 760273102 |
| — | FS DEV CORP | 1,000,000 | $11.2M | 0.2% | $11.20 | $11.20 | — | COM CL A | 303020101 |
| — | ARYA SCIENCES ACQUISITION CO | 1,000,000 | $10.81M | 0.2% | $10.81 | $10.81 | — | COM CL A | G3166W106 |
| — | VERASTEM INC | 8,066,171 | $9.76M | 0.2% | $1.21 | $2.64 | — | COM | 92337C104 |
| — | SOLID BIOSCIENCES INC | 4,571,164 | $9.279M | 0.2% | $2.03 | $8.67 | — | COM | 83422E105 |
| — | LYRA THERAPEUTICS INC | 815,849 | $9.252M | 0.2% | $11.34 | $11.34 | — | COM | 55234L105 |
| — | ARYA SCIENCES ACQUISITION CORP | 700,000 | $7.7M | 0.1% | $11.00 | $11.60 | — | UNIT 06/09/2027 | G31655114 |
| GRTX | GALERA THERAPEUTICS INC | 825,118 | $7.459M | 0.1% | $9.04 * | $12.19 | -35.0% | COM | 36338D108 |
| — | HEALTH SCIENCES ACQ CORP 2 | 625,000 | $6.875M | 0.1% | $11.00 | $11.00 | — | ORD SHS | G4411D109 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 353,072 | $5.236M | 0.1% | $14.83 * | $4.43 | +164.3% | COM NEW | 15117B202 |
| — | IMARA INC | 249,739 | $5.08M | 0.1% | $20.34 | $16.03 | — | COM | 45249V107 |
| — | PASSAGE BIO INC | 322,630 | $4.23M | 0.1% | $13.11 | $15.75 | — | COM | 702712100 |
| — | X4 PHARMACEUTICALS INC | 559,494 | $3.788M | 0.1% | $6.77 | $12.24 | — | COM | 98420X103 |
| — | ESSA PHARMA INC | 470,428 | $3.246M | 0.1% | $6.90 | $3.37 | — | COM NEW | 29668H708 |
| OVID | OVID THERAPEUTICS INC | 285,000 | $1.636M | 0.0% | $5.74 * | $4.68 | +43.1% | COM | 690469101 |